Prednisolone Sodium Phosphate

Ophthalmia, Sympathetic, Collagen Diseases, Uveitis + 12 more
Treatment
14 FDA approvals
20 Active Studies for Prednisolone Sodium Phosphate

What is Prednisolone Sodium Phosphate

Prednisolone phosphateThe Generic name of this drug
Treatment SummaryPrednisolone phosphate is a steroid medication with anti-inflammatory, immune-suppressing, anti-tumor, and blood vessel narrowing effects. It is commonly used to treat a variety of conditions including allergic reactions, autoimmune disorders, and cancer. Prednisolone phosphate was approved by the FDA in 1973.
Pediapredis the brand name
image of different drug pills on a surface
Prednisolone Sodium Phosphate Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Pediapred
Prednisolone phosphate
1986
71

Approved as Treatment by the FDA

Prednisolone phosphate, also called Pediapred, is approved by the FDA for 14 uses such as Endocrine Disorders and Allergic Conditions .
Endocrine Disorders
Allergic Conditions
Multiple Sclerosis
Disease
Ocular Inflammation
Neoplastic Disease
Ophthalmia, Sympathetic
Gastroenteritis
Uveitis
Respiratory Diseases
Temporal Arteritis
Dermatological Disease
Collagen Diseases
Swollen feet or ankles

Effectiveness

How Prednisolone Sodium Phosphate Affects PatientsPrednisolone works by blocking inflammation-causing signals, and has a short half-life of 2-4 hours. It is usually taken in doses much higher than the body naturally produces, making it easy to find the right dose for a patient. People taking prednisolone should be aware of the risks of suppressing their body's natural hormone production and increased susceptibility to infections.
How Prednisolone Sodium Phosphate works in the bodyCorticosteroids, like prednisone, reduce inflammation by decreasing swelling in the capillaries and preventing white blood cells from rushing to the area. This is done by changing gene expression, which has other effects like limiting the formation of arachidonic acid and promoting anti-inflammatory proteins. Lower doses have an anti-inflammatory effect, while higher doses suppress your immune system. A long-term high dose of corticosteroids can also raise sodium levels and reduce potassium levels.

When to interrupt dosage

The suggested dosage of Prednisolone Sodium Phosphate is reliant upon the diagnosed condition, including Uveitis, Ocular Inflammation and Ophthalmia, Sympathetic. The measure of dosage fluctuates, in line with the technique of administration specified in the table underneath.
Condition
Dosage
Administration
Ophthalmia, Sympathetic
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Urinary Tract Infection (UTI)
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Collagen Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Ocular Inflammation
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Dermatological Disease
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Swollen feet or ankles
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Uveitis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Endocrine Disorders
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Gastroenteritis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Neoplastic Disease
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Temporal Arteritis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Disease
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Multiple Sclerosis
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Allergic Conditions
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral
Respiratory Diseases
15.0 mg/mL, , 25.0 mg/mL, 10.0 mg, 15.0 mg, 30.0 mg, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 20.0 mg/mL, 1.0 %, 0.125 %, 0.5 %, 2.3 mg/mL, 1.25 mg/mL
, Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Liquid; Solution / drops, Liquid; Solution / drops - Ophthalmic, Liquid - Oral

Warnings

Prednisolone Sodium Phosphate has a single contraindication and should not be taken in combination with the conditions in the below table.Prednisolone Sodium Phosphate Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Prednisolone Phosphate may interact with Pulse Frequency
There are 20 known major drug interactions with Prednisolone Sodium Phosphate.
Common Prednisolone Sodium Phosphate Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be decreased when it is combined with Prednisolone phosphate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Prednisolone phosphate.
Aldesleukin
Major
The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone phosphate.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Prednisolone phosphate.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Prednisolone phosphate.
Prednisolone Sodium Phosphate Toxicity & Overdose RiskThere is limited information available regarding overdoses on prednisone. Chronic overdosage may cause mental problems, a round face, fat deposits in unusual places, and water retention. In cases of acute oral overdose, treatment with vomiting or stomach pumping may be necessary, as well as other supportive treatments. Long-term overdoses can be managed by taking a lower dose or alternating doses.
image of a doctor in a lab doing drug, clinical research

Prednisolone Sodium Phosphate Novel Uses: Which Conditions Have a Clinical Trial Featuring Prednisolone Sodium Phosphate?

115 active clinical trials are being conducted to analyze the potential of Prednisolone Sodium Phosphate for the relief of Ocular Inflammation, Uveitis, Ophthalmia and Sympathetic Disorders.
Condition
Clinical Trials
Trial Phases
Ophthalmia, Sympathetic
0 Actively Recruiting
Allergic Conditions
0 Actively Recruiting
Neoplastic Disease
1 Actively Recruiting
Phase 1
Multiple Sclerosis
0 Actively Recruiting
Disease
0 Actively Recruiting
Temporal Arteritis
0 Actively Recruiting
Endocrine Disorders
0 Actively Recruiting
Collagen Diseases
0 Actively Recruiting
Dermatological Disease
0 Actively Recruiting
Ocular Inflammation
3 Actively Recruiting
Phase 2, Phase 4, Phase 3
Respiratory Diseases
3 Actively Recruiting
Not Applicable
Uveitis
15 Actively Recruiting
Phase 2, Phase 3, Phase 4, Not Applicable, Phase 1
Gastroenteritis
29 Actively Recruiting
Phase 2, Not Applicable, Phase 3, Phase 1
Urinary Tract Infection (UTI)
24 Actively Recruiting
Phase 2, Phase 1, Phase 4, Phase 3, Not Applicable
Swollen feet or ankles
40 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 3, Phase 4

Prednisolone Sodium Phosphate Reviews: What are patients saying about Prednisolone Sodium Phosphate?

5Patient Review
10/18/2014
Prednisolone Sodium Phosphate for Asthma
It provides quick relief.
4.3Patient Review
10/15/2007
Prednisolone Sodium Phosphate for Sarcoidosis
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about prednisolone sodium phosphate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is prednisolone sodium phosphate prescribed for?

"The drug is used to treat a variety of conditions, including arthritis, blood disorders, immune system disorders, skin and eye conditions, breathing problems, cancer, and severe allergies. The drug works by decreasing the immune system's response to various diseases, which reduces symptoms such as pain, swelling, and allergic-type reactions."

Answered by AI

What are the side effects of prednisolone sodium phosphate?

"The following side effects may occur: nausea, heartburn, headache, dizziness, menstrual period changes, trouble sleeping, increased sweating, or acne. If you experience any of these effects for an extended period of time, or if they worsen, consult your doctor or pharmacist."

Answered by AI

When should you take prednisolone sodium phosphate?

"1-2 drops in the eyes every 1-2 hours until the condition is controlled, then the frequency can be reduced. 2-3 drops in the ear every 2-3 hours until the condition is controlled, then the frequency can be reduced. The frequency of doses given will depend on how the patient responds."

Answered by AI

Is prednisolone a sodium phosphate?

"Prednisolone sodium phosphate is an organic sodium salt of prednisolone phosphate. It is a drug used to treat short-term inflammatory eye conditions. It works by relieving inflammation, redness and irritation of the eyes."

Answered by AI

Clinical Trials for Prednisolone Sodium Phosphate

Have you considered Prednisolone Sodium Phosphate clinical trials? We made a collection of clinical trials featuring Prednisolone Sodium Phosphate, we think they might fit your search criteria.
Have you considered Prednisolone Sodium Phosphate clinical trials? We made a collection of clinical trials featuring Prednisolone Sodium Phosphate, we think they might fit your search criteria.
Have you considered Prednisolone Sodium Phosphate clinical trials? We made a collection of clinical trials featuring Prednisolone Sodium Phosphate, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top